The estimated Net Worth of Todd Foley is at least $184 Millón dollars as of 9 July 2021. Mr. Foley owns over 27,351 units of Rhythm Pharmaceuticals stock worth over $110,584,381 and over the last 11 years he sold RYTM stock worth over $72,931,898. In addition, he makes $247,843 as Independent Director at Rhythm Pharmaceuticals.
Todd has made over 38 trades of the Rhythm Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 27,351 units of RYTM stock worth $917,626 on 9 July 2021.
The largest trade he's ever made was selling 1,000,000 units of Rhythm Pharmaceuticals stock on 15 March 2021 worth over $25,100,000. On average, Todd trades about 63,592 units every 53 days since 2014. As of 9 July 2021 he still owns at least 2,242,636 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Mr. Foley stock trades at the bottom of the page.
Todd Foley serves as Independent Director of the Company. Mr. Foley has served as a member of our Board since 2014. Mr. Foley is a managing director with MPM Capital, a venture capital firm. Mr. Foley joined MPM Capital in 1999. Prior to joining MPM Capital, Mr. Foley worked in business development at Genentech, Inc. and in management consulting with Arthur D. Little, Inc. Mr. Foley currently serves as a member of the board of directors of Chiasma, Inc. Mr. Foley also serves on the boards of directors of numerous private companies, including Coda Biotherapeutics, Inc., Iconic Therapeutics, Inc., Repare Therapeutics Inc., Entrada Therapeutics, Inc. and Tetherex Pharmaceuticals, Inc. Mr. Foley received a B.S. in chemistry from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.
As the Independent Director of Rhythm Pharmaceuticals, the total compensation of Todd Foley at Rhythm Pharmaceuticals is $247,843. There are 12 executives at Rhythm Pharmaceuticals getting paid more, with Hunter Smith having the highest compensation of $1,922,850.
Todd Foley is 48, he's been the Independent Director of Rhythm Pharmaceuticals since 2014. There are 12 older and 5 younger executives at Rhythm Pharmaceuticals. The oldest executive at Rhythm Pharmaceuticals Inc. is Dr. David P. Meeker M.D., 67, who is the Chairman, Pres & CEO.
Todd's mailing address filed with the SEC is C/O MPM CAPITAL, 450 KENDALL STREET, CAMBRIDGE, MA, 02142.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over $83,445,563 worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth $106,961,700 . The most active insiders traders include Forest Baskett, Scott D Sandell y Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of $3,358,405. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth $77,963.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: